TD SYNNEX CORP·4

Jan 30, 6:05 PM ET

HUME RICHARD T 4

4 · TD SYNNEX CORP · Filed Jan 30, 2026

Research Summary

AI-generated summary of this filing

Updated

TD SYNNEX (SNX) Director Richard Hume Exercises Options, Sells Shares

What Happened

  • Richard T. Hume, a director of TD SYNNEX (SNX), exercised stock options and then sold the resulting shares. On Jan 28–29, 2026 he exercised a total of 37,991 options at a strike price of $107.32 (cost = $4,077,194) and sold the same 37,991 shares in open-market transactions for aggregate proceeds of $6,099,711. Net proceeds (sales minus exercise cost) were approximately $2,022,517.
  • Transaction types shown on the Form 4: M = option exercises (acquisitions at the strike) and S = open-market sales (dispositions). The filings indicate the exercised shares were sold immediately (a cashless-like sequence).

Key Details

  • Dates: Jan 28, 2026 and Jan 29, 2026; Form filed Jan 30, 2026 (timely within SEC Form 4 reporting window).
  • Exercise: 12,991 shares on 1/28 and 25,000 shares on 1/29 at $107.32 per share (total paid $4,077,194).
  • Sales (open market): 12,745 @ $160.32, 246 @ $161.15, 18,080 @ $160.50, 6,920 @ $161.12 — total shares sold 37,991; total proceeds $6,099,711. Weighted average sale price roughly $160.56.
  • Related derivative lines: the filing also lists derivative-disposition line items at $0.00 that correspond to the option conversions reported on the same form.
  • Footnotes: transactions were executed under a Rule 10b5-1 trading plan adopted July 14, 2025 (F1). Several footnotes (F2–F5) note sales were effected at prices within specified ranges and that detailed per-price quantities are available on request. F6 notes the option was fully vested.
  • Shares owned after the transactions: not provided in the excerpt supplied.

Context

  • This is a common pattern where an insider exercises vested options and sells the shares immediately under a pre-established 10b5-1 plan — generally viewed as routine liquidity rather than a directional endorsement of the stock.
  • The Form 4 shows the exercise and the matching sales; because all exercised shares were sold, there was no net increase in the insider’s shareholding from these transactions.

Insider Transaction Report

Form 4
Period: 2026-01-28
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-28$107.32/sh+12,991$1,394,19460,506 total
  • Sale

    Common Stock

    [F1][F2]
    2026-01-28$160.32/sh12,745$2,043,27847,761 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-28$161.15/sh246$39,64347,515 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-29$107.32/sh+25,000$2,683,00072,515 total
  • Sale

    Common Stock

    [F1][F4]
    2026-01-29$160.50/sh18,080$2,901,84054,435 total
  • Sale

    Common Stock

    [F1][F5]
    2026-01-29$161.12/sh6,920$1,114,95047,515 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F1][F6]
    2026-01-2812,99143,857 total
    Exercise: $107.32Exp: 2031-10-05Common Stock (12,991 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F1][F6]
    2026-01-2925,00018,857 total
    Exercise: $107.32Exp: 2031-10-05Common Stock (25,000 underlying)
Footnotes (6)
  • [F1]The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.
  • [F2]Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.955. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
  • [F3]Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.02 to $161.50. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
  • [F4]Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.99. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
  • [F5]Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.00 to $161.52. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
  • [F6]This stock option is fully vested.
Signature
/s/ Cheryl Grant, attorney-in-fact|2026-01-30

Documents

1 file
  • 4
    wk-form4_1769814310.xmlPrimary

    FORM 4